These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 9568641

  • 1. The influence of antiestrogens on the release of plasminogen activator (uPA) by MDA-MB-231 and MCF-7 breast cancer cells.
    Abidi SM, Howard EW, Dmytryk JJ, Pento JT.
    Clin Exp Metastasis; 1998 Apr; 16(3):235-41. PubMed ID: 9568641
    [Abstract] [Full Text] [Related]

  • 2. Differential influence of antiestrogens on the in vitro release of gelatinases (type IV collagenases) by invasive and non-invasive breast cancer cells.
    Abbas Abidi SM, Howard EW, Dmytryk JJ, Pento JT.
    Clin Exp Metastasis; 1997 Jul; 15(4):432-9. PubMed ID: 9219732
    [Abstract] [Full Text] [Related]

  • 3. Influence of antiestrogens on the migration of breast cancer cells using an in vitro wound model.
    Mathew AC, Rajah TT, Hurt GM, Abbas Abidi SM, Dmytryk JJ, Pento JT.
    Clin Exp Metastasis; 1997 Jul; 15(4):393-9. PubMed ID: 9219727
    [Abstract] [Full Text] [Related]

  • 4. Agonist activity of antiestrogen-receptor complexes to regulate urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) endogenous gene expression in breast cancer cells.
    Levenson AS, Svoboda KM, Kwaan HC, Jordan VC.
    Cancer Lett; 1998 Mar 13; 125(1-2):215-20. PubMed ID: 9566718
    [Abstract] [Full Text] [Related]

  • 5. Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness.
    Holst-Hansen C, Johannessen B, Høyer-Hansen G, Rømer J, Ellis V, Brünner N.
    Clin Exp Metastasis; 1996 May 13; 14(3):297-307. PubMed ID: 8674284
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Treatment with the pure antiestrogen faslodex (ICI 182780) induces tumor necrosis factor receptor 1 (TNFR1) expression in MCF-7 breast cancer cells.
    Smolnikar K, Löffek S, Schulz T, Michna H, Diel P.
    Breast Cancer Res Treat; 2000 Oct 13; 63(3):249-59. PubMed ID: 11110059
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE, Madsen MW, Briand P.
    Cancer Res; 1994 Mar 15; 54(6):1587-95. PubMed ID: 8137264
    [Abstract] [Full Text] [Related]

  • 12. Western immunoblotting and enzymatic activity analysis of cathepsin D in human breast cancer cell lines of different invasive potential. Regulation by 17beta-estradiol, tamoxifen and ICI 182,780.
    Couissi D, Dubois V, Remacle C, Schonne E, Trouet A.
    Clin Exp Metastasis; 1997 Jul 15; 15(4):349-60. PubMed ID: 9219723
    [Abstract] [Full Text] [Related]

  • 13. Additive growth inhibitory effects of ibandronate and antiestrogens in estrogen receptor-positive breast cancer cell lines.
    Journe F, Chaboteaux C, Magne N, Duvillier H, Laurent G, Body JJ.
    Breast Cancer Res; 2006 Jul 15; 8(1):R2. PubMed ID: 16417650
    [Abstract] [Full Text] [Related]

  • 14. Acquired antiestrogen resistance in MCF-7 human breast cancer sublines is not accomplished by altered expression of receptors in the ErbB-family.
    Larsen SS, Egeblad M, Jäättelä M, Lykkesfeldt AE.
    Breast Cancer Res Treat; 1999 Nov 15; 58(1):41-56. PubMed ID: 10634517
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Influence of antiestrogens on the invasiveness and laminin attachment of breast cancer cells.
    Rajah TT, Pento JT.
    Cancer Invest; 1999 Nov 15; 17(1):10-8. PubMed ID: 10999044
    [Abstract] [Full Text] [Related]

  • 17. Effect of antiestrogens and aromatase inhibitor on basal growth of the human breast cancer cell line MCF-7 in serum-free medium.
    Jensen J, Kitlen JW, Briand P, Labrie F, Lykkesfeldt AE.
    J Steroid Biochem Mol Biol; 2003 Mar 15; 84(4):469-78. PubMed ID: 12732292
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.
    Katzenellenbogen BS, Norman MJ, Eckert RL, Peltz SW, Mangel WF.
    Cancer Res; 1984 Jan 15; 44(1):112-9. PubMed ID: 6537799
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.